[1] 岳璇,刘莉.结节性硬化症临床研究进展[J].国际儿科学杂志,2018,45(9):714-718.
[2] EBRAHIMI-FAKHARI D,MANN L L,PORYO M,et al.Correction to:incidence of tuberous sclerosis and age at first diagnosis:new data and emerging trends from a national,prospective surveillance study[J].Orphanet J Rare Dis,2019,14(1):106.
[3] 邓劼,王旭.结节性硬化症遗传学研究及诊断与治疗进展[J].中国现代神经疾病杂志,2018,18(6):385-390.
[4] RAMLAUL K,FU W,LI H,et al.Architecture of the tuberous sclerosis protein complex[J].J Mol Biol,2021,433(2):166743.
[5] YANG H,YU Z,CHEN X,et al.Structural insights into TSC complex assembly and GAP activity on Rheb[J].Nat Commun,2021,12(1):339.
[6] NORTHRUP H,KRUEGER D A.Tuberous sclerosis complex diagnostic criteria update:recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference[J].Pediatr Neurol,2013,49(4):243-254.
[7] 孙平平,马少春.儿童结节性硬化症1例报告并文献复习[J].中风与神经疾病杂志,2021,38(3):260-261.
[8] 宋春泽,蒋国平,叶菁菁,等.小儿结节性硬化症合并心脏横纹肌瘤临床特征研究[J].临床小儿外科杂志,2019,18(9):767-770.
[9] 陈湘湘,袁天明.6月龄以内婴儿结节性硬化症临床特征分析[J].临床儿科杂志,2019,37(6):436-439.
[10] 赵青青,韩蕴丽,阮毅燕,等.儿童结节性硬化症伴癫痫发作71例临床分析[J].中国医药导报,2020,17(20):107-110.
[11] LIN S,ZENG J B,ZHAO G X,et al.Tuberous sclerosis complex in Chinese patients:phenotypic analysis and mutational screening of TSC1/TSC2 genes[J].Seizure,2019,71:322-327.
[12] CHIVUKULA S,MODIRI O,KASHANIAN A.Effect of gene mutation on seizures in surgery for tuberous sclerosis complex[J].Can J Neurol Sci,2021,48(3):327-334.
[13] 邹丽萍,刘玉洁,庞领玉,等.雷帕霉素治疗儿童结节性硬化症合并癫痫的临床效果及安全性观察[J].中华儿科杂志,2014,52(11):812-816.
[14] 艾美辰,吴晓云.儿童结节性硬化症相关性心脏横纹肌瘤的诊治进展[J].儿科药学杂志,2020,26(5):57-60.
[15] 杨坤琨,蒋莉.结节性硬化症相关癫痫的临床特征及治疗进展[J].儿科药学杂志,2017,23(4):58-61.
[16] KOTULSKA K,KWIATKOWSKI D J,CURATOLO P,et al.Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial[J].Ann Neurol,2021,89(2):304-314.
[17] 徐东,朱琳,何琳,等.NOTCH2基因突变致婴儿Hajdu-Cheney综合征一例并文献复习[J].现代医学,2021,49(3):332-334. |